Cargando…
Carboplatin therapeutic monitoring in preterm and full-term neonates
INTRODUCTION: Administration of the most appropriate dose of chemotherapy to neonates is particularly challenging and frequently not standardised based on any scientific rationale. We report the clinical utility of carboplatin therapeutic drug monitoring in preterm and full-term neonates within the...
Autores principales: | Veal, Gareth J., Errington, Julie, Hayden, James, Hobin, David, Murphy, Dermot, Dommett, Rachel M., Tweddle, Deborah A., Jenkinson, Helen, Picton, Susan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4571926/ https://www.ncbi.nlm.nih.gov/pubmed/26232270 http://dx.doi.org/10.1016/j.ejca.2015.07.011 |
Ejemplares similares
-
Generation of evidence-based carboplatin dosing guidelines for neonates and infants
por: Barnett, Shelby, et al.
Publicado: (2023) -
Vincristine dosing, drug exposure and therapeutic drug monitoring in neonate and infant cancer patients
por: Barnett, Shelby, et al.
Publicado: (2022) -
Pharmacokinetics and Safety of a Novel Oral Liquid Formulation of 13-cis Retinoic Acid in Children with Neuroblastoma: A Randomized Crossover Clinical Trial
por: Veal, Gareth J., et al.
Publicado: (2021) -
Pharmacokinetics and Pharmacogenetics of Cyclophosphamide in a Neonate and Infant Childhood Cancer Patient Population
por: Barnett, Shelby, et al.
Publicado: (2021) -
Adaptive dosing of anticancer drugs in neonates: facilitating evidence-based dosing regimens
por: Veal, Gareth J., et al.
Publicado: (2016)